- ABOUT ME
- AREAS OF FOCUS
- EDUCATION & LEADERSHIP
- LOCATIONS & HOSPITALS
- NEWS & PUBLICATIONS
Dr. Srivastava was first introduced to the field of Radiation Oncology when his brother-in-law was diagnosed with a glioblastoma. This experience showed Dr. Srivastava that a cancer diagnosis affects both a patient and their family and taught him to experience cancer care from the patient’s perspective. Dr. Srivastava was amazed by how a radiation oncologist can support both patients and families during one of the most difficult times of their lives and integrate advances in cancer care into the clinic to directly improve the lives of their patients. His favorite part of his job is telling a patient that they are in remission and/or have no evidence of disease after they have undergone an extensive course of cancer-directed therapies.
Dr. Srivastava was trained in Magnetic Resonance-Guided Radiation Therapy (MRgRT) during residency at the first center to utilize this technology in the U.S. and has over 4 years of experience with this technology. He is trained in MR-based adaptive radiotherapy, offered at The Oregon Clinic Radiation Oncology. Dr. Srivastava also brings extensive training in gynecologic and genitourinary high-dose rate brachytherapy, which is used to treat cervical/endometrial cancers and prostate cancer, respectively.
Dr. Srivastava enjoys living in Portland because of the unique and wonderful culture of the city. He also likes that the city is very walkable, has great restaurants, and is only an hour away from mountains, waterfalls, hiking trails, and beaches.
Outside of work, Dr. Srivastava likes cooking and experimenting with new recipes, spending time with his partner, their dog and cats, and taking in the city and surrounding nature.
Other Activities
Member, American Society for Radiation Oncology (ASTRO)
Member, European Society for Radiotherapy and Oncology (ESTRO)
Member, Radiologic Society of North America (RSNA)
Member, American Radium Society (ARS)
Member, American Board of Radiology
Areas of Focus
Intensity Modulated Radiation Therapy (IMRT)
Gastrointestinal Cancers
Magnetic Resonance- Guided Radiation Therapy (MRgRT)
Stereotactic Body Radiation Therapy (SBRT)
CT and MR-based Adaptive Radiotherapy (ART)
Genitourinary Cancers, including Prostate, Bladder, Testis
Gynecologic Cancers
High Dose Rate (HDR) Brachytherapy
LGBTQI Health and Cancer Disparities
EDUCATION & TRAINING
Residency, Barnes-Jewish Hospital, Washington University, St. Louis, MO, 2020
Internship, Mercy Hospital, St. Louis, MO, 2016
MD, Johns Hopkins University School of Medicine, Baltimore, MD, 2015
MPH, Johns Hopkins University School of Public Health, Baltimore, MD, 2014
BS, Yale University, New Haven, CT, 2010
BOARD CERTIFICATION
Radiation Oncology – Board Eligible
HONORS
ASTRO Press Program, 2019
ESTRO Annual Meeting Travel Award (2018)
Recognition of Excellence- Transitional Year Intern (2016)
TL1 Clinical Research Training Award (2013)
Reed-Frost Scholarship Award for Public Health (2013)
Excellence in Medical Student Research Award (2012)
William R Belknap Award for Excellence in Biological Studies (2010)
Phi Beta Kappa Honor Society (2009)
Yale College Dean’s Research Fellowship (2009)
AT&T Foundation Scholarship (2006)
Locations
Hospitals Served
- Providence Portland Medical Center
- Providence St. Vincent Medical Center
Publications
Srivastava AJ, Contreras JA, Davis M, Markovina ST, Schwarz JK, Grigsby PW. Early Post-Therapy Clearance of Human Papillomavirus and Treatment Response in Cervical Carcinoma. Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040. Online ahead of print.
Barnes JM, Srivastava AJ, Gabani P, Perkins SM. Associations of early Medicaid expansion with insurance status and stage at diagnosis among cancer patients receiving radiation therapy. Pract Radiat Oncol. Jul-Aug 2020;10(4):e207-e218. doi: 10.1016/j.prro.2019.10.003. Epub 2019 Oct 18.
Gabani P, Merfeld E, Srivastava AJ, Weiner AA, Ochoa LL, Mullen D, Thomas MA, Margenthaler JA, Cyr AE, Peterson LL, Naughton MJ, Ma C, Zoberi I. Predictors of Locoregional Recurrence in Patients Who Fail to Achieve Pathological Complete Response After Neoadjuvant Chemotherapy in Triple Negative Breast Cancer. J Natl Compr Canc Netw. 2019 Apr 1;17(4):348-356.
Fischer-Valuck BW, Chen I, Srivastava AJ, Floberg JM, Rao YJ, King AA, Shinohara ET, Perkins SM. Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database. Cancer. 2017 Feb 15;123(4):682-687.
Geetha D, Lee SK, Srivastava AJ, Kraus ES, Wright SM. Clinical excellence in nephrology: Examples from the published literature. BMC Nephrol. 2015 Aug 15;16:141.
Srivastava A, Rao GK, Segal PE, Shah M, Geetha D. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Clin Rheumatol. 2013 Sep;32(9):1317-22.
Raman G, Srivastava A, Geetha D. Outcome of renal transplantation in patients with both ANCA and anti-GBM antibodies. Transplantation. 2012 Sep 15;94(5):e30-1.